brentuximab vedotin
seagen,takeda
['lymsm', 'hodgkin', 'lymphoma']
great to see dr ansell present an overall survival benefit with bvavd cf abvd in untreated hodgkin lymphoma, also lower second malignancies &amp; good fertility rates; though with increased neuropathy #echelon1 #lymsm #asco22 
haematology registrar | evidence-based medicine | MPH @Harvard | health policy @PORTAL_research | physiology | musician | writer | @_futurethinkers cofounder